Information Journal Paper
APA:
CopySCHETTINI, F.. (2016). NABPACLITAXEL FOR THE TREATMENT OF TRIPLE NEGATIVE BREAST CANCER: RATIONALE, CLINICAL DATA AND FUTURE PERSPECTIVES. CANCER TREATMENT REVIEW, 50(-), 129-141. SID. https://sid.ir/paper/713932/en
Vancouver:
CopySCHETTINI F.. NABPACLITAXEL FOR THE TREATMENT OF TRIPLE NEGATIVE BREAST CANCER: RATIONALE, CLINICAL DATA AND FUTURE PERSPECTIVES. CANCER TREATMENT REVIEW[Internet]. 2016;50(-):129-141. Available from: https://sid.ir/paper/713932/en
IEEE:
CopyF. SCHETTINI, “NABPACLITAXEL FOR THE TREATMENT OF TRIPLE NEGATIVE BREAST CANCER: RATIONALE, CLINICAL DATA AND FUTURE PERSPECTIVES,” CANCER TREATMENT REVIEW, vol. 50, no. -, pp. 129–141, 2016, [Online]. Available: https://sid.ir/paper/713932/en